Computational and experimental strategies for functional validation of non-coding variants in pancreatic cancer

Abstract Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy characterised by extensive genomic heterogeneity and limited therapeutic options. Although recurrent coding mutations in key driver genes have been well researched, large-scale sequencing studies have identified a broad array of non-coding variants which may contribute to tumorigenesis by interfering with gene regulatory mechanisms. However, understanding the functional significance of these variants remains a major challenge due to their abundance and the complexity of non-coding regulatory structures. This review outlines current computational and experimental techniques to identify, prioritise, and functionally validate non-coding variants in PDAC. We discuss in silico methods including genome-wide association study (GWAS) fine-mapping, colocalisation, machine learning-driven functional annotation, and the use of established computational tools, in addition to epigenomic profiling technologies including, ATAC-seq, ChIP-seq, and CUT&RUN which define regulatory landscapes. We also emphasise new AI-based methods involving radiogenomics, AI imaging analysis and data integration, which provides novel potential to link genomic variation with phenotypic and imaging characteristics. Additionally, we highlight experimental validation techniques including reporter assays, electrophoretic mobility shift assays (EMSA), chromatin conformation capture methods, and CRISPR-based perturbation systems used to study variant functionality. Together, these complementary approaches establish a framework for correlating non-coding variation to regulatory mechanisms in PDAC.

Authors

Publication Details

Journal
Functional & Integrative Genomics
Published
2026-11-17
DOI
https://doi.org/10.1007/s10142-026-02116-3
Primary Topic
Pancreatic and Hepatic Oncology Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Computational and experimental strategies for functional validation of non-coding variants in pancreatic cancer

Murat Güler, Roberto Giovannoni, Alex J. Eustace, Pelin Unal et al.
Functional & Integrative Genomics
Pancreatic and Hepatic Oncology Research
article

Computational and experimental strategies for functional validation of non-coding variants in pancreatic cancer

Murat Güler, Roberto Giovannoni, Alex J. Eustace, Pelin Unal, Elif Arik Sever, Jane Herlihy, Riccardo Farinella, Daniele Campa, Naomi Walsh, Karla Jenkac
article en

Abstract

Abstract Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy characterised by extensive genomic heterogeneity and limited therapeutic options. Although recurrent coding mutations in key driver genes have been well researched, large-scale sequencing studies have identified a broad array of non-coding variants which may contribute to tumorigenesis by interfering with gene regulatory mechanisms. However, understanding the functional significance of these variants remains a major challenge due to their abundance and the complexity of non-coding regulatory structures. This review outlines current computational and experimental techniques to identify, prioritise, and functionally validate non-coding variants in PDAC. We discuss in silico methods including genome-wide association study (GWAS) fine-mapping, colocalisation, machine learning-driven functional annotation, and the use of established computational tools, in addition to epigenomic profiling technologies including, ATAC-seq, ChIP-seq, and CUT&RUN which define regulatory landscapes. We also emphasise new AI-based methods involving radiogenomics, AI imaging analysis and data integration, which provides novel potential to link genomic variation with phenotypic and imaging characteristics. Additionally, we highlight experimental validation techniques including reporter assays, electrophoretic mobility shift assays (EMSA), chromatin conformation capture methods, and CRISPR-based perturbation systems used to study variant functionality. Together, these complementary approaches establish a framework for correlating non-coding variation to regulatory mechanisms in PDAC.

Functional & Integrative GenomicsVol. 26(1)
Pancreatic and Hepatic Oncology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon